(Q48668080)

14 February 2018

title

Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma. (English)

1 reference

14 February 2018

0 references

5

1 reference

14 February 2018

Bernhard Radlwimmer

21

1 reference

14 February 2018

Michael Platten

22

1 reference

14 February 2018

Stefan M. Pfister

23

1 reference

14 February 2018

Dominik Sturm

Dominik Sturm

6

0 references

Michael Weller

25

Michael Weller

1 reference

14 February 2018

26

Wolfgang Wick

1 reference

14 February 2018

24

Andreas von Deimling

1 reference

14 February 2018

19

Guido Reifenberger

1 reference

14 February 2018

2

David Capper

1 reference

PubMed ID

25008768

14 February 2018

Christel Herold-Mende

14

Christel Herold-Mende

1 reference

14 February 2018

3

Martin Sill

1 reference

14 February 2018

20

Peter Lichter

1 reference

14 February 2018

Andrey Korshunov

10

Andrey Korshunov

1 reference

14 February 2018

David T. W. Jones

4

David T W Jones

1 reference

14 February 2018

Christian Koelsche

7

Christian Koelsche

1 reference

14 February 2018

Patrick Roth

15

Patrick Roth

1 reference

14 February 2018

Leonille Schweizer

9

Leonille Schweizer

1 reference

14 February 2018

Maximilian G. Schliesser

12

Maximilian G Schliesser

1 reference

14 February 2018

author name string

Benedikt Wiestler

1

1 reference

14 February 2018

Anna Bertoni

8

1 reference

14 February 2018

Elisa K Weiß

11

1 reference

14 February 2018

Alexander Radbruch

13

1 reference

14 February 2018

Andreas Unterberg

16

1 reference

14 February 2018

Christian Hartmann

17

1 reference

14 February 2018

Torsten Pietsch

18

1 reference

14 February 2018

publication date

10 July 2014

1 reference

14 February 2018

published in

Acta Neuropathologica

1 reference

14 February 2018

volume

128

1 reference

14 February 2018

page(s)

561-571

1 reference

14 February 2018

issue

4

1 reference

14 February 2018

https://scigraph.springernature.com/pub.10.1007/s00401-014-1315-x

exact match

0 references

cites work

MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

The somatic genomic landscape of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

The integrated landscape of driver genomic alterations in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Altered telomeres in tumors with ATRX and DAXX mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

MGMT testing--the challenges for biomarker-based glioma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1315-X

10.1007/S00401-014-1315-X

21 January 2018

Identifiers

DOI

1 reference

14 February 2018

release_rbi6bjaurrcjna5t2c5x3534iq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rbi6bjaurrcjna5t2c5x3534iq

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

25008768

1 reference

14 February 2018